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Objective. To evaluate the safety of electrocautery for coagulation during Caesarean sections. Study Design. A randomized,
controlled, clinical pilot study was performed at a university maternity hospital. After admission for delivery and decision to
perform a C-section, volunteers were randomized to either the intervention group (use of electrocautery for coagulation) or
nonintervention group. The women were examined at the time of postpartum discharge (day 3), at days 7 to 10, and again at
days 30 to 40 for signs of infection, hematoma, seroma, or dehiscence. Data were analyzed using an intention-to-treat analysis,
and risk ratios were calculated. Results. No significant differences were found between the two groups. Only 2.8% of patients in
the intervention group developed surgical wound complications during hospitalization. However, 7 to 10 days following discharge,
these rates reached 23.0% and 15.4% in the intervention and nonintervention groups, respectively (RR = 1.50, 95% CI = 0.84–2.60).
Conclusion. Further studies should confirm whether the use of electrocautery for coagulation does not increase the risk of surgical
wound complications in patients undergoing Caesarean sections.
1. Introduction
The surgical technique for Caesarean sections (C-sections)
has undergone multiple changes aimed at improving patient
outcomes. Among these changes, the use of electrocautery for
obstetrical procedures was introduced according to recom-
mendations arising fromdevelopments in general surgery [1].
Electrosurgery is expected to reduce the surgical duration
because of beneficial homeostatic interventions. However,
electrosurgery is also associated with potential complications
including internal and external burns, seromas, and surgical
scar infections [1–4]. Previous studies have suggested that
infectious complications are a cause for concern [5, 6].
However, in a randomized study of oncologic patients who
underwent laparotomy in which electrocautery was used for
tissue cutting and hemostasis, no differences were found
between the electrocautery and control group [7].
Nevertheless, no studies have been conducted on the
possible complications associated with the use of surgical
electrocautery in pregnant women. The United Kingdom’s
National Health System manual, which is based on avail-
able evidence, reports that there are no data on which to
recommend the use of electrocautery in C-sections [8]. This
institution considers that current evidence is insufficient to
recommend the use of electrocautery in C-sections [9].
On the other hand, there are no reports of adverse effects
associated with the use of electrocautery in newborns, even
in intrauterine fetal surgery in high-voltage electric currents
are used for periods of up to 30 minutes [10, 11].
In view of the reported increase in the performance of C-
sections and use of electrocautery combined with the scarcity
of pertinent data, a pilot study was performed to evaluate the
efficacy and safety of the use of electrocautery for coagulation
on surgical wound healing in patients undergoing C-section.
2. Material and Methods
We performed a randomized, controlled, clinical pilot study
on the use of electrocautery for coagulation in C-sections.
Because no previous studies have been performed on this
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topic, sample size calculation was based on a presumed
15.0% increase in surgical wound complications with the use
of electrocautery for coagulation, a 33.0% prevalence of C-
section deliveries in thematernity hospital in which the study
was performed, and a 14.4% postdischarge infection rate [12].
An additional 20.0% was added to compensate for patients
who may be lost to follow-up during the study, totaling a
sample of 224 women.
Women admitted for delivery at the obstetrical unit of a
university maternity teaching hospital in Campinas, State of
Sa˜o Paulo, Brazil, who had received prenatal care and who
had no hemostatic problems, were invited to participate in
the study. Admission to the study was dependent on the
need to perform a C-section, which was determined by the
obstetrical team at any point during labour. Patients in whom
a C-section was indicated as an emergency procedure (e.g.,
for treatment of placental abruption), patients who have used
antibiotics in the 30 days preceding delivery, and patients
who had undergone more than one previous C-section were
excluded from the study. The women who were invited to
participate in the study received information regarding the
procedures to be carried out and signed an informed consent
form before the mode of delivery was defined.
When a C-section was indicated, admission criteria were
checked and informed consent was obtained. The next step
involved randomization to one of two groups: patients who
did and did not undergo the use of electrocautery. This was
accomplished by opening the next in a series of 224 brown
envelopes available at the delivery room. Those envelopes
indicated to which of the two groups each woman was
assigned according to the randomization list generated by the
SAS statistical software program version 9.1. The operating
room nurse sequentially opened the envelopes.
If the use of electrocautery was required in patients allo-
cated to the nonintervention group, this protocol deviation
was to be annotated; however, no such situation occurred
during the study period. All patients received prophylac-
tic antibiotic therapy during delivery, as a single dose of
cephalothin after the umbilical cord had been clamped.
After the procedure had been performed, the patient was
blindly reevaluated by the investigator on the day of hospital
discharged (postpartum day 3), at days 7 to 10, and at days
30 to 40. At each evaluation, the surgical scar was examined
for signs of infection, hematoma, seroma, or dehiscence.
Neither the volunteers nor the investigator who performed
the evaluation at the three above-mentioned time points were
aware of treatment. The patient was discontinued from the
study if she was found to have an infection at any site other
than the C-section scar.
The results were analyzed using an intention-to-treat
approach. The chi-square test and Fisher’s exact test were
used for categorical variables, and the Mann-Whitney test
was used for interval variables. Risk ratio and correspondent
95% confidence intervals were calculated. The database was
constructed using Epi Info 6, version 1.0. The statistical
analysis was performed using the SAS software package,
version 9.1.
The surgical technique and the appropriate use of elec-
trocautery were part of a preparatory training program
for surgeons (residents, contracted physicians, and faculty).
This program included a discussion session and distribution
of written material. Clinical evaluations during follow-up
period were carried out by the same investigator together
with another physician in all cases, and in any cases of
discord, a third observer was consulted. All collected data
were entered into the database and checked in duplicate.
The study protocol was approved by the Internal Review
Board of the School ofMedical Sciences, University of Camp-
inas (UNICAMP) under approval number 1036/2008 as well
as by the Internal Review Board of the Celso PierroHospital
and Maternity Home. All participants signed an informed
consent form [13].
3. Results
Between March and July 2009, a total of 977 deliveries
were performed and 633 women were invited to participate
in the study prior to establishing the type of delivery. Of
these women, 25 refused to participate (15 due to difficulty
in attending scheduled follow-up visits and 10 for various
other reasons). Of the 608 women who signed as informed
consent form, the 224 underwent C-sectionwere randomized
to the two above-described groups. Four were eliminated
from analysis (two due to use of prophylactic antibiotics after
prolonged urethral catheterization and two due to antibiotic
use for postpartumurinary infection). No electrocautery pro-
tocol deviation occurred. Fifteen women in the intervention
group and 16 in the nonintervention group did not return
for the 30- to 40-day evaluation; therefore, 97 patients in
the intervention group and 96 in the nonintervention group
completed the protocol, including the late evaluation visit at
days 30 to 40 (Figure 1).
There were no statistical differences in demographic
characteristics, parity, prenatal care, or weight between the
two groups. The mean age of the women was 24 years, and
they had a mean of 10 years of schooling. In terms of marital
status, 70% lived with a partner; of those who lived alone,
96% had a steady sexual partner. The patients had attended
as average of nine prenatal consultations, had an initial mean
body mass index of 25.3 kg/m2, and had gained a mean of
12 kg during pregnancy. Most patients (60%) were in their
second pregnancy. One-third of the women in both groups
(34%) had already undergone one C-section (Table 1).
In 80% of cases, performance of the C-section was
indicated during labor by the physician for reasons pri-
marily associated with fetal compromise (26%) and failed
labor induction (11%). There were 14 cases and 17 cases of
preeclampsia in the intervention nonintervention groups,
respectively. The incidence of diabetes in both groups was
1%.
All patients underwent spinal anaesthesia with the excep-
tion of one woman in whom general anaesthesia was neces-
sary. In both groups, 71% of the procedures were performed
by a year 2 resident with the assistance of year 1 resi-
dent under staff supervision. Intraoperative complications
includedmaternal supraventricular tachycardia, change from
cephalic to breech presentation, bladder lesions, epidural
block failure, and termination of the anaesthetic effect prior
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977 deliveries
March–July 2009
633 women were invited to
participate
25 women refused to
participate
608 signed informed consent
form
384 vaginal deliveries
224 women who underwent
C-sections were randomized
12 women discontinued 8 women discontinued
postpartum postpartum
3 women discontinued 8 women discontinued
postpartum postpartum
(use of electrocautery) (without electrocautery)
112 women—treatment 112 women—no treatment
100 women at days 7–10 104 women at days 7–10
97 women at days 30–40      96 women at days 30–40
Figure 1: Flow chart of admission to and exclusion from the study.
Table 1: Demographic characteristics, parity, and prenatal care in pregnant women submitted to C-sections with and without the use of
electrocautery.
Variable With electrocautery Without electrocautery
𝑛 Mean SD Median 𝑛 Mean SD Median
Age (years) 109 24.9 6.5 23.0 111 24.5 6.4 23.0
Schooling (years) 109 10.0 1.7 11.0 111 9.7 1.8 11.0
Pregnancies 109 1.79 1.00 2.00 111 2.01 1.17 2.00
Caesarean sections 109 0.34 0.48 0.00 111 0.38 0.49 0.00
Weight (kg) at first antenatal visit 109 64.9 16.2 61.0 111 66.2 15.6 64.0
Weight (kg) at final antenatal visit 109 76.8 16.9 73.0 111 77.3 15.3 76.0
Initial BMI 109 25.3 5.9 23.6 108 25.4 5.0 25.0
Gestational age (weeks) 108 39.1 1.8 39.4 107 39.0 1.7 39.3
BMI: body mass index; SD: standard deviation.
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Table 2: Surgical scar complications on day 3 following C-section
with and without the use of electrocautery.
Treatment (use of electrocautery)
Yes No
𝑁 % 𝑁 %
Hematoma
No 109 100.0 111 100.0
Seroma
No 108 99.1 111 100.0
Yes 1 0.9 0
Infection
No 106 97.2 111 100.0
Yes 3 2.8 3
to the end of surgery; these complications predominated in
the nonintervention group.
The total time of the surgical procedure (from anaesthesia
to completion of the C-section) was similar in both groups:
100 and 105 minutes in the intervention and nonintervention
groups, respectively (𝑃 = 0.54). The surgeon’s training
was not associated with the incidence of surgical wound
complications (𝑃 = 0.57). Neonatal findings were similar in
both groups, and no newborn infants had cardiac arrhythmia
at birth (data not shown).
During hospitalization, only 2.8% of the women devel-
oped a surgical scar complication (hematoma, seroma, dehis-
cence, or signs of infection), and all of these complications
occurred in the electrocautery group. Three women devel-
oped signs of infection, which were associated with a seroma
in one patient (Table 2). In the evaluation performed between
days 7 and 10, when stitches were removed, a significant
increase in the complications ratewas found: 23.0%and 15.4%
in the intervention and nonintervention groups, respectively.
Seroma was the most common complication (17.0% and
11.5%, resp.), followed by signs of infection, dehiscence, and
hematoma. There was no difference in the distribution of
complications between the two groups (Table 3).
Few women reported complications at the 30- to 40-day
evaluation (Table 4). At the time of stitch removal (days 7–
10), a risk ratio of 1.5 was found for complications compared
with discharge, which was not statistically significant (95%
CI = 0.84–2.60). At the final postpartum check-up, 23.0% and
18.8% of the women in the intervention and nonintervention
groups, respectively, were found to have some form of
surgical wound complication (RR = 1.21; 95% CI = 0.69–2.11).
Nevertheless, there was no increase in the accumulated risk
of developing a complication (seroma, hematoma, infection,
or dehiscence) at the three evaluation time points (hospital
discharge, return to the hospital for removal of stitches, and
the final postpartum follow-up visit) (Table 5).
Of the women who were found to have a C-section scar
complication at the time of stitch removal (days 7–10), 14.1%
and 10.6%of patients in the intervention and nonintervention
groups, respectively, received antibiotics (cephalexin). Only
Table 3: Surgical scar complications between days 7 and 10 after C-
section with and without the use of electrocautery.
Treatment (use of electrocautery)
Yes No
𝑛 % 𝑛 %
Hematoma
No 98 98.0 104 100.0
Yes 2 2.0 0
Seroma
No 83 83.0 92 83.0
Yes 17 17.0 12 11.5
Infection
No 90 90.0 95 91.3
Yes 10 10.0 9 8.7
Table 4: Surgical scar complications between days 30 and 40
following C-section with and without the use of electrocautery.
Treatment (use of electrocautery)
Yes No
𝑛 % 𝑛 %
Hematoma
No 97 100.0 95 99.0
Yes 1 1.0
Seroma
No 97 100.0 93 96.9
Yes 3 3.1
Infection
No 97 100.0 93 96.9
Yes 3 3.1
one woman in the electrocautery group required hospital-
ization to drain a hematoma and resuture the wall. Another
woman with a hematoma required no intervention.
4. Comment
Among women who had undergone zero to one previous
C-section, no significant differences were found in surgical
wound complications (seroma, hematoma, signs of infection,
and dehiscence) at the three different time points (postpar-
tum days 3-4, 7–10, and 30–40) between women submitted to
C-section in whom electrocautery was used for homeostasis
or coagulation and those in whom no electrocautery was
used. Preparation of the medical team involved in this
study included classes with printed material on care during
hemostasis and the prevention of surgical infection, which
may have had a positive effect on the results found in the two
groups.
Unfortunately, we found no previous studies on the
additional risk of surgical wound complications following C-
section in which electrocautery for homeostasis was used for
comparison of our results. The intervention evaluated in this
study reduced the total time of the procedure by only five
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Table 5: Accumulated surgical scar complications∗ assessed during follow-up, according to the use of electrocautery for hemostasis.
Treatment (use of electrocautery)
𝑃-value RRYes No
𝑛 % 𝑛 %
Any complication prior to discharge
No 106 97.2 111 100 0.1199 Not calculable
Yes 3 2.8 0
Any complication up to postpartum days 7–10
No 77 77.0 88 84.6 0.1667∗ 1.50 (0.84–2.60)
Yes 23 23.0 16 15.4
Any complication up to postpartum days 30–40
No 77 77.0 78 81.3 0.5006∗ 1.21 (0.69–2.11)
Yes 23 23.0 18 18.8
∗includes hematoma, seroma, dehiscence, and signs of infection.
minutes, which was surprising. The C-section was expected
to take much longer without the use of cautery because of the
need for suture hemostasis. However, the total time of surgery
was high in both groups, which can be explained by the fact
thatmost of theC-sectionswere performed by year 2 and year
1 obstetrics and gynecology residents, who were expected to
increase the duration of surgery by more than 50% [14].
Contrary to our expectations, all intraoperative clinical
complications occurred in women in whom electrocautery
was not used. On the other hand, the two hematomas found
between days 7 and 10 occurred, surprisingly, in women in
whom electrocautery had been used. The assumption that
avoidance of cautery could be associated with a higher risk
of hematoma certainly contributed towards the extreme care
used in hemostatic suturing, thereby resulting in a reduction
in the occurrence of hematomas in this group.
No statistically significant differences were found in the
Apgar scores of the newborn infants in the two groups,
and no complications occurred. These results were expected
because the amount of electrical energy used in the mother
was less than that used in fetal surgery procedures and lasted
for a shorter period of time [9, 10]. Moreover, electrical
energy must be disseminated to act directly on tissues [3],
and the various layers of tissue and the placenta separating
the fetus from the electrocauterizer may act as protection.
Finally, biosafety regulations are implemented to guarantee
that energy is grounded through the fastest route, thus not
affecting the fetus [1].
The increase in postdischarge complications was similar
in both groups and was in agreement with the postdischarge
surveillance rates reported in other publications both in
Brazil and abroad. Dantas [12] reported that 75% of signs
of C-section scar infections become apparent between days
7 and 11, reaching 95% by day 14 after discharge. Creedly
and Noy [15] reported an infection rate of 2.8% during
hospitalization that increased to 17.0% when the women
responded to a questionnaire 30 days after discharge. The
infection rates in the electrocautery group (10.0%) and that in
the nonintervention group (8.7%) at days 7 to 10 in the present
randomized pilot study were lower than those reported by
other national authors (14.4% and 17%, resp.), but were
similar to those reported in other international publications
[16–18].
Seromas were the most common complication in both
groups; however, they occurred more frequently in the elec-
trocautery group. This finding was expected because electro-
cautery promotes coagulation by breaking down molecules
via lipolysis. Nevertheless, evenwithout the use of this device,
the incidence of seromas was high. Other factors, such as the
thickness of subcutaneous tissue, may also be associated with
this complication. The mean body mass index was similar in
both groups and was indicative of a borderline overweight
status, a fact that may have contributed to these rates.
Even with complications occurring in around one-fifth
of C-section scars, all the women had recovered by day 40
postpartum and their scars had healed with no hematomas,
seromas, or signs of infection. However, this pilot study
evaluated only functional and not aesthetic aspects and failed
to assess patient satisfaction with respect to the scar.
Findings may be different in other populations. In addi-
tion, other factors that could be associated with the presence
of complications, such as maternal anaemia, were not evalu-
ated. Nevertheless, this was a population of pregnant women
with reasonable nutritional and educational status, with a
mean body mass index compatible with overweight status,
and in whom no greater risk of surgical scar complications
was found with the use of electrocautery.
The results of this randomized study are based on the
CONSORT guidelines [2, 19]. The principal limitation of this
clinical trial was the lack of previous studies that would have
permitted calculation of a sample size sufficient to confirm
or discard the possibility of risks associated with the use of
electrocautery in C-sections. Sample size had to be calculated
based on a study of infectious surgical scar complications
detected during postdischarge surveillance with no mention
of cautery. The rates reported in this study were used to
represent the nonintervention group, and it was assumed that
the intervention would double the risk of complications.
Nevertheless, the incidence of infectious complications
in the 224 women in the 2 groups was lower than expected,
increasing the type I error. A 50% increase in the risk of
complicationswas found, but it was not significant.Moreover,
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the rates of infection in the intervention and nonintervention
groups were only 10.0% and 8.7%, respectively, which were
lower than predicted based on previous studies on infection
rates. Therefore, this randomized trial is a pilot study that
may serve as a basis for the calculation of sample sizes in
further studies in which greater statistical power may supply
more conclusive results. Whether the use of electrocautery
increases the incidence of complications in C-section scars
remains unconfirmed despite a relative risk of 1.5, wide
confidence interval, and difference is not considered to be
statistically significant.
Because of these limitations, a definitive change in C-
section guidelines regarding hemostasis cannot be recom-
mended. Further studies with greater statistical power must
be performed to increase the current knowledge on the use
of electrocautery for both coagulation and tissue cutting in
procedures performed in pregnant women. It is reasonable
to suggest, however, that as recommended, the obstetrician
should use electrocautery sparingly for coagulation during
surgery, and only when suture hemostasis is contraindicated.
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